Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. AQST has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
AQST stock price ended at $2.38 on Friday, after rising0%
The Aquestive Therapeutics Inc stock price increased by 0% on the last trading day (16 May 2025), rising from 2.38 to 2.38. Throughout the last trading session, the stock experienced a fluctuation of 5.77% , ranging from a day low of $2.34 to a day high of 2.475. The price has declined in 4 of the last 10 days, resulting in a total change of -20.67% during this period. On the last day, trading volume increase by -824.45K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 2.57M shares were traded, amounting to approximately 6.19M.
AQST Technical Signals
AQST(Aquestive Therapeutics Inc Corp) has 3 buy signals and 3 sell signals now. The current trend is consolidation starting from 2025-05-12. The total price change during this trend is -10.70%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of AQST over the last 5 trading days is 7.79M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
AQST Moving Average Analysis
Aquestive Therapeutics Inc's overall moving average trend leans more bearish as of Saturday, May 17, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $3.187288666666667, and $3.5421666666666667. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $2.039044666666667, and $1.684166666666667. A break-down below any of these levels will issue sell signals.
AQST Short Selling Analysis
The short sale ratio of Aquestive Therapeutics Inc(AQST) as of 12 May 2025 is 17.07%, rising from last trading day. With increasing price from 2.79 to 2.85. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
3
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-108.365
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
15.529
Bullish
Moving Average
Price crosses above 5-day SMA
--
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.171
Bearish
Momentum (10 days)
MOM_10 < 0
-0.455
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.0739
Bearish
AQST Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Aquestive Therapeutics Inc(AQST), our algorithm predicts AQST's 1-month price at $3.03, with an 8.7%upwardshift. Using a similarity score up to 93.94%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Aquestive Therapeutics Inc (AQST.O) stock, as of Sunday, May 11, 2025 , forecasts a 8.7% change over the next month, based on its high correlation with IRON.O stock patterns. The similarity between their price movements over the analyzed periods is 93.94%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
AQST
No Data
IRON
Up: 8.7%Similarity: 93.94%
Name
Similarity
Up/Down
IRON.O
93.94%
+8.70%
SUNS.O
93.88%
+3.98%
SIMO.O
93.28%
+14.22%
TENX.O
92.95%
-10.11%
BCTX.O
92.93%
+24.94%
ATXS.O
92.91%
-6.38%
ARWR.O
92.87%
-1.60%
SWKH.O
92.85%
-1.28%
ENIC.N
92.77%
-11.32%
ESRT.N
92.67%
+0.41%
AQST Seasonality Analysis
Based on AQST's historical stock price data across all years, the probability of a positive return in May is28.57%, suggesting it maynotbe an ideal month to invest in AQST. In contrast,Augustoffers the highest probability of positive returns at83.33%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Aquestive Therapeutics Inc (AQST.O) stock in August has the highest probability of a positive return (83.33%), while December has the lowest probability (0.00%).
Performance Seasonality
The chart shows Aquestive Therapeutics Inc. (AQST)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Aquestive Therapeutics Inc (AQST.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. AQST has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Aquestive Therapeutics Inc (AQST.O) stock in a year?
The radar chart shows that buying Aquestive Therapeutics Inc (AQST.O) stock in August has the highest probability of a positive return (83.33%), while December has the lowest probability (0.00%).
How has Aquestive Therapeutics Inc. (AQST)'s stock price performed over the past three years?
AQST's stock price rose by 124.44% in 2023,increased by 77.11% in 2024, and went down by 35.15% in 2025.
Is AQST a buy based on overall technical signals summary?
AQST has 3 buy signals and 3 sell signals now. Overall the technical rating for AQST is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of AQST.
What is the trend of Aquestive Therapeutics Inc (AQST)'s moving average?
Aquestive Therapeutics Inc's overall moving average trend leans more bearish as of May 17 2025, with 4 negative signals and 0 positive signal.
What is price prediction for AQST stock next month?
The price prediction chart for Aquestive Therapeutics Inc (AQST.O) stock, as of May 11 2025, forecasts a 8.7% change over the next month, based on its high correlation with IRON stock patterns. The similarity between their price movements over the analyzed periods is 93.94%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for AQST Stock?
Aquestive Therapeutics (AQST) stock is predicted to trade between **$1.80 and $4.20** by Q4 2025.
- **Bullish Scenario**: The stock could rise to **$4.20** if Anaphylm gains FDA approval and shows strong pre-launch momentum.
- **Bearish Scenario**: The stock may drop to **$1.80** if regulatory delays occur or revenue guidance is missed.
The prediction is based on the company's Q4 financial performance and upcoming FDA review of Anaphylm.
What is price prediction 2030 for AQST Stock?
### **Price Prediction for AQST Stock by 2030**
- **$15**: Conservative estimate, assuming moderate growth and successful commercialization of Anaphylm with limited market penetration.
- **$25**: Bullish scenario, driven by strong demand for Anaphylm and expansion into new markets.
- **$5**: Bearish case, if the company faces significant regulatory or commercialization challenges.
**Reasons**:
- **Anaphylm Launch**: Positive pediatric trial results and upcoming FDA review in Q2 2025 position AQST for potential market expansion.
- **Valuation**: Current low stock price with upside potential if products gain traction.
- **Pipeline Strength**: Strong development pipeline beyond Anaphylm supports long-term growth.